Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events

Journal of Neuroscience

Volumn 22, Issue 17, 2002, Pages 7526-7535

  Noble, Linda J ^a,b   Donovan, Frances ^a   Igarashi, Takuji ^a   Goussev, Staci ^a   Werb, Zena ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood spinal cord barrier; Inflammation; Locomotor recovery; Matrix metalloproteinase 9; Proteinases; Spinal cord injury

Indexed keywords

GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; INFLAMMATION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SPINAL CORD INJURY; WHITE MATTER;

EID: 0036758650     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-17-07526.2002     Document Type: Article

References (64)

1. Adler RR, Brenner CA, Werb Z (1990) Expression of extracellular matrix-degrading metalloproteinases and metalloproteinase inhibitors is developmentally regulated during endoderm differentiation of embryonal carcinoma cells. Development 110:211-220.
2. Anthony DC, Ferguson B, Matyzak MK, Miller KM, Esiri MM, Perry VH (1997) Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol Appl Neurobiol 23:406-415.
3. Armao D, Kornfeld M, Estrada EY, Grossetete M, Rosenberg GA (1997) Neutral proteases and disruption of the blood-brain barrier in rat. Brain Res 767:259-264.
4. Austyn JM, Gordon S (1981) F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 11:805-815.
5. Backstrom JR, Lim GP, Cullen MJ, Tokes ZA (1996) Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-β peptide (1-40). J Neurosci 16:7910-7919.
6. Banda MJ, Clark EJ, Werb Z (1980) Limited proteolysis by macrophage elastase inactivates human alpha 1-proteinase inhibitor. J Exp Med 152:1563-1570.
7. Bartholdi D, Schwab ME (1995) Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat. Brain Res 672:177-186.
8. Basso DM, Beattie MS, Bresnahan JC (1995) A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12:1-21.
9. Basso DM, Beattie MS, Bresnahan JC, Anderson DK, Faden AI, Gruner JA, Holford TR, Hsu CY, Noble LJ, Nockels R, Perot PL, Salzman SK, Young W (1996) MASCIS evaluation of open field locomotor scores: Effects of experience and teamwork on reliability. Multicenter Animal Spinal Cord Injury Study. J Neurotrauma 13:343-359.
10. Behrendtsen O, Alexander CM, Werb Z (1992) Metalloproteinases mediate extracellular matrix degradation by cells from mouse blastocyst outgrowths. Development 114:447-456.
11. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA (1993) Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 4:197-250.
12. Blight AR (1985) Delayed demyelination and macrophage invasion: A candidate for secondary cell damage in spinal cord injury. Cent Nerv Syst Trauma 2:299-315.
13. Blight AR (1994) Effects of silica on the outcome from experimental spinal cord injury: Implication of macrophages in secondary tissue damage. Neuroscience 60:263-273.
14. Bolton SJ, Anthony DC, Perry VH (1998) Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience 86:1245-1257.
15. Carlson SL, Parrish ME, Springer JE, Doty K, Dossett L (1998) Acute inflammatory response in spinal cord following impact injury. Exp Neurol 151:77-88.
16. Chen R, Fleming MG, Dias LA, Werb Z, Liu Z (2001) Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest 108:1151-1158.
17. Cuzner ML, Gveric D, Strand C, Loughlin AJ, Paemen L, Opdenakker G, Newcombe J (1996) The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: Comparison of stages in lesion evolution. J Neuropathol Exp Neurol 55:1194-1204.
18. Delclaux C, Delacourt C, D'Ortho MP, Boyer V, Lafuma C, Harf A (1996) Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 14:288-295.
19. Dusart I, Schwab ME (1994) Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci 6:712-724.
20. Farkas E, Luiten PG (2001) Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 64:575-611.
21. Fujimura M, Gasche Y, Morita-Fujimura Y, Massengale J, Kawase M, Chan PH (1999) Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res 842:92-100.
22. Gijbels K, Proost P, Masure S, Carton H, Billiau A, Opdenakker G (1993) Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein. J Neurosci Res 36:432-440.
23. Gijbels K, Galardy RE, Steinman L (1994) Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J Clin Invest 94:2177-2182.
24. Gledhill RF, Harrison BM, McDonald WI (1973) Demyelination and remyelination after acute spinal cord compression. Exp Neurol 38:472-487.
25. Gottschall PE, Deb S (1996) Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. Neuroimmunomodulation 3:69-75.
26. Griffiths IR, McCulloch MC (1983) Nerve fibres in spinal cord impact injuries. Part 1. Changes in the myelin sheath during the initial 5 weeks. J Neurol Sci 58:335-349.
27. Herron GS, Werb Z, Dwyer K, Banda MJ (1986) Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity. J Biol Chem 261:2810-2813.
28. Hibbs MS, Hoidal JR, Kang AH (1987) Expression of a metallo-proteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J Clin Invest 80:1644-1650.
29. Kalaria RN (2000) The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 21:321-330.
30. Kuhn PL, Wrathall JR (1998) A mouse model of graded contusive spinal cord injury. J Neurotrauma 15:125-140.
31. Lim GP, Backstrom JR, Cullen MJ, Miller CA, Atkinson RD, Tokes ZA (1996) Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients. J Neurochem 67:251-259.
32. Liu Z, Shipley JM, Vu TH, Zhou X, Diaz LA, Werb Z, Senior RM (1998) Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J Exp Med 188:475-482.
33. Liu Z, Zhou X, Shapiro SD, Shipley JM, Twining SS, Diaz LA, Senior RM, Werb Z (2000) The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell 102:647-655.
34. Maeda A, Sobel RA (1996) Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J Neuropathol Exp Neurol 55:300-309.
35. Mainardi CL, Hibbs MS, Hasty KA, Seyer JM (1984) Purification of a type V collagen degrading metalloproteinase from rabbit alveolar macrophages. Coll Relat Res 4:479-492.
36. Mun-Bryce S, Rosenberg GA (1998a) Matrix metalloproteinases in cerebrovascular disease. J Cereb Blood Flow Metab 18:1163-1172.
37. Mun-Bryce S, Rosenberg GA (1998b) Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am J Physiol 274:R1203-R1211.
38. Murphy G, Ward R, Hembry RM, Reynolds JJ, Kuhn K, Tryggvason K (1989) Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase. Biochem J 258:463-472.
39. Noble LJ, Wrathall JR (1985) Spinal cord contusion in the rat: Morphometric analyses of alterations in the spinal cord. Exp Neurol 88:135-149.
40. Noble LJ, Wrathall JR (1989a) Distribution and time course of protein extravasation in the rat spinal cord after contusive injury. Brain Res 482:57-66.
41. Noble LJ, Wrathall JR (1989b) Correlative analyses of lesion development and functional status after graded spinal cord contusive injuries in the rat. Exp Neurol 103:34-40.
42. Oh LY, Larsen PH, Krekoski CA, Edwards DR, Donovan F, Werb Z, Yong VW (1999) Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J Neurosci 19:8464-8475.
43. Pluznik DH, Fridman R, Reich R (1992) Correlation in the expression of type IV collagenase and the invasive and chemotactic abilities of myelomonocytic cells during differentiation into macrophages. Exp Hematol 20:57-63.
44. Popovich PG, Horner PJ, Mullin BB, Stokes BT (1996) A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury. Exp Neurol 142:258-275.
45. Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC (1998) Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: Inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29:1020-1030.
46. Rosenberg GA, Navratil M (1997) Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology 48:921-926.
47. Rosenberg GA, Dencoff JE, McGuire PG, Liotta LA, Stetler-Stevenson WG (1994) Injury-induced 92-kilodalton gelatinase and urokinase expression in rat brain. Lab Invest 71:417-422.
48. Rosenberg GA, Estrada EY, Dencoff JE, Stetler-Stevenson WG (1995) Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: An expanded therapeutic window. Brain Res 703:151-155.
49. Rosenberg GA, Navratil M, Barone F, Feuerstein G (1996a) Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab 16:360-366.
50. Rosenberg GA, Dencoff JE, Correa Jr N, Reiners M, Ford CC (1996b) Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: Relation to blood-brain barrier injury. Neurology 46:1626-1632.
51. Rosenberg GA, Estrada EY, Dencoff JE (1998) Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29:2189-2195.
52. Schlosshauer B (1993) The blood-brain barrier: Morphology, molecules, and neurothelin. BioEssays 15:341-346.
53. Sires UI, Murphy G, Baragi VM, Fliszar CJ, Welgus HG, Senior RM (1994) Matrilysin is much more efficient than other matrix metalloproteinases in the proteolytic inactivation of alpha 1-antitrypsin. Biochem Biophys Res Commun 204:613-620.
54. Sternlicht MDWZ (1999) Extracellular matrix proteinases. In: Guidebook to the Extracellular Matrix, Anchor and Adhesion Proteins (Kreis T, Vale R, eds), pp 503-603. New York: Oxford UP.
55. Sternlicht MDWZ (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463-516.
56. Taoka Y, Okajima K, Uchiba M, Murakami K, Kushimoto S, Johno M, Naruo M, Okabe H, Takatsuki K (1997) Role of neutrophils in spinal cord injury in the rat. Neuroscience 79:1177-1182.
57. Taoka Y, Okajima K, Murakami K, Johno M, Naruo M (1998) Role of neutrophil elastase in compression-induced spinal cord injury in rats. Brain Res 799:264-269.
58. Vu TH, Werb Z (1998) Gelatinase B: Structure, Regulation, and Function. San Diego: Academic.
59. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411-422.
60. Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320:365-376.
61. Werb Z (1997) ECM and cell surface proteolysis: Regulating cellular ecology. Cell 91:439-442.
62. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI (1989) SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem [Erratum (1990) 265:22570] 264:17213-17221.
63. Xu J, Kim G-M, Ahmed S, Xu J, Yan P, Xu X, Hsu CY (2001) Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury. J Neurosci 21:92-97.
64. Yong VW, Power C, Forsyth P, Edwards DR (2001) Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2:502-511.